In present study, we revealed that ZLM-7 could block cell-cycle progression and therefore inhibit tumor growth and progression of breast cancer, depending on the regulation of the 14-3-3 sigma/MDM2 axis. This evidence concerns the gene MDM2 and neoplasm.